Jennifer Price Howard

Jennifer Price Howard has a diverse work experience spanning multiple industries. Jennifer Price is currently working at Noven Pharmaceuticals as a Senior Manager, Business Analytics since April 2022. Prior to that, they worked at Vitro3D as a Commercial Specialist from March 2021 to June 2022.

From 2015 to 2020, Jennifer worked at Silvergate Pharmaceuticals, Inc. where they held multiple roles. Jennifer Price was the Manager, Commercial Business Analytics from October 2016 to February 2020. In this role, they managed the organization's commercial data, analysis, and reporting, and supported in four successful product launches. Jennifer Price also worked closely with the CEO and VP of Marketing on sales operations, sales forecasting, KPIs, product market maps, and strategic targeting processes. Prior to this role, they worked as a Data Analyst from September 2015 to October 2016.

In 2015, Jennifer briefly worked at Gryphon Technologies, LC as a Marketing Lead Analyst, Business Development. In this role, they were responsible for end-to-end marketing for government contracting opportunities and assisted in proposal preparation.

Before that, they gained experience at BB&T as a Teller from June 2007 to December 2014 while obtaining their undergraduate degrees. Additionally, they worked at Blue Ridge Aviation as an Independent Strategist Consultant - Aviation Internship from May 2010 to December 2013.

Jennifer Price Howard began their education journey in 2008 at Old Dominion University, where they pursued a Bachelor of Science degree in Human Services and Counseling. Jennifer Price completed this program in 2010. Following that, from 2010 to 2014, Jennifer attended the same university and obtained another Bachelor of Science degree, this time in Business Administration with a specialization in Business Analytics.

In 2020, Jennifer embarked on a new educational endeavor, enrolling at the University of Colorado Boulder. Jennifer Price pursued a Master of Business Administration (MBA) degree, which they completed in 2022. Unfortunately, specific details regarding their area of focus or field of study during their MBA program are not provided.